Detalhe da pesquisa
1.
Changes in Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Over Time in 10 Sites in the United States, March-August, 2020.
Clin Infect Dis
; 73(10): 1831-1839, 2021 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33639620
2.
Comparison of Estimated Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Through Commercial Laboratory Residual Sera Testing and a Community Survey.
Clin Infect Dis
; 73(9): e3120-e3123, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33300579
3.
Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Reactive Antibodies: December 2019-January 2020.
Clin Infect Dis
; 72(12): e1004-e1009, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33252659
4.
Development and validation of a robust multiplex serological assay to quantify antibodies specific to pertussis antigens.
Biologicals
; 57: 9-20, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30458978
5.
Examination of SARS-CoV-2 serological test results from multiple commercial and laboratory platforms with an in-house serum panel.
Access Microbiol
; 6(2)2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38482357
6.
Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination.
Vaccine
; 41(28): 4183-4189, 2023 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37244808
7.
Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations.
J Clin Microbiol
; 49(6): 2210-5, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21471339
8.
Minimum public health standards as a basis for secure public health funding.
J Public Health Manag Pract
; 10(1): 19-22, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15018336